Are you a pharmacist experienced in managing chemotherapy induced nausea and vomiting?

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review the eLearning content for CINV. If you are currently managing policies related to CINV, have a minimum experience of 3 years in oncology, we would be delighted to have you apply as a reviewer.

As part of this important role we kindly request you to provide the following details:

Your current role and title:
Place of work: 

Additionally, we ask that you submit a brief statement (no more than 300 words) explaining why you are well suited for this role.

Your insights and expertise are crucial in ensuring the quality and relevance of our content.

To apply, please email [email protected]. Please note, applications will close on Monday 16th September and we will let candidates know the outcome by 21st September.

The selected reviewer will be remunerated for their valuable time and dedication to this initiative. We understand the significance of your contributions and as a token of appreciation, the reviewer will be acknowledged on our website.

Thank you for considering this opportunity, and we appreciate your continued dedication to enhancing healthcare knowledge.

Best wishes,

BOPA eLearning Team

Latest News

By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Education & Training Subcommittee on 3rd May 2025

NEW eLearning module for Myeloma now live

Dear BOPA members,   The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article